
    
      This is a prospective, multicenter, single arm clinical registry investigating the safety and
      efficacy of polymer-free sirolimus-eluting coronary stent system (NANO plus) in patients with
      coronary artery disease . In total, we plan to recruit 2500 patients in real world setting.
      The patients will be followed clinically at 1-, 6- month and 1-, 2-, 3-, 4-, 5-year. All
      clinical data will be collected and managed by statistical center, clinical endpoint
      adjudication committee.
    
  